Alkermes reports 30% rise in sales of key drug
Company pulls full-year guidance on coronavirus disruption to healthcare systems
Losses dip slightly at Alkermes to $72.6m
Dublin-headquartered biopharma company saw rise in revenues for quarter to $191.8m
Alkermes executives take a hit on pay package
Irish-domiciled biopharma group reported 31% rise in sales last year
Alkermes loss rises to $77m in first quarter
Biopharma company reports sales of $156 million, down from $161 million in 2015
Alkermes looks to schizophrenia drug approval as sales jump 24%
Heavy investment in R&D and set-up costs for new therapies push biopharma group to $30.6m loss
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices